CareLit · DOI-Nachweis · Pneumologie
VPM1002: A new TB prime vaccine on the horizon
DOI 10.1055/s-0033-1363139
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Minhas, L Grode, M Cotton, G Walzl, A Hesseling, SHE Kaufmann, B Eisele
ZeitschriftPneumologie
Ausgabe02/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: VPM1002 is a live vaccine against TB being developed by VPM together with Serum Institute of India. It is based on Mycobacterium bovis Bacille Calmette-Guérin (BCG) strain which has been applied appr. 4 billion times worldwide. As BCG is not sufficiently effective to stop the spread of tuberculosis, two modifications have been implemented in VPM1002 to improve its immunogenicity. Our clinical development…
Zitieren
Zitierempfehlung
A Minhas, L Grode, M Cotton, G Walzl, A Hesseling, SHE Kaufmann, B Eisele (2014) VPM1002: A new TB prime vaccine on the horizon. Pneumologie (02). https://doi.org/10.1055/s-0033-1363139
Mit CareLit weiterarbeiten